Li‐Chung Chiu

843 total citations
50 papers, 549 citations indexed

About

Li‐Chung Chiu is a scholar working on Pulmonary and Respiratory Medicine, Critical Care and Intensive Care Medicine and Oncology. According to data from OpenAlex, Li‐Chung Chiu has authored 50 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 12 papers in Critical Care and Intensive Care Medicine and 12 papers in Oncology. Recurrent topics in Li‐Chung Chiu's work include Respiratory Support and Mechanisms (21 papers), Lung Cancer Treatments and Mutations (11 papers) and Mechanical Circulatory Support Devices (10 papers). Li‐Chung Chiu is often cited by papers focused on Respiratory Support and Mechanisms (21 papers), Lung Cancer Treatments and Mutations (11 papers) and Mechanical Circulatory Support Devices (10 papers). Li‐Chung Chiu collaborates with scholars based in Taiwan, United States and China. Li‐Chung Chiu's co-authors include Kuo‐Chin Kao, Cheng‐Ta Yang, Chung-Chi Huang, Han‐Chung Hu, Chen‐Yiu Hung, Chih-Hao Chang, Li‐Fu Li, Li‐Pang Chuang, Shih‐Wei Lin and Ning‐Hung Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Li‐Chung Chiu

48 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Li‐Chung Chiu Taiwan	15	354	143	131	99	91	50	549
Hans‐Dieter Walmrath Germany	8	529 1.5×	46 0.3×	81 0.6×	17 0.2×	203 2.2×	13	870
Fernando Mosteiro Spain	6	405 1.1×	88 0.6×	166 1.3×	7 0.1×	194 2.1×	12	579
Ashham Mansur Germany	14	44 0.1×	63 0.4×	73 0.6×	29 0.3×	205 2.3×	38	471
Kevin Pilarczyk Germany	12	89 0.3×	120 0.8×	106 0.8×	8 0.1×	67 0.7×	57	458
Vincent Tchana‐Sato Belgium	15	262 0.7×	116 0.8×	114 0.9×	14 0.1×	165 1.8×	54	715
Hiroaki Hiraiwa Japan	12	57 0.2×	68 0.5×	27 0.2×	74 0.7×	57 0.6×	80	495
Hermann Goehl Australia	11	74 0.2×	47 0.3×	26 0.2×	61 0.6×	95 1.0×	13	621
Ilona Bobek Hungary	11	68 0.2×	47 0.3×	60 0.5×	14 0.1×	67 0.7×	24	492
Gustavo Neves de Araújo Brazil	11	66 0.2×	41 0.3×	29 0.2×	46 0.5×	65 0.7×	40	427
Paul Johnston United Kingdom	9	232 0.7×	21 0.1×	57 0.4×	13 0.1×	217 2.4×	17	568

Countries citing papers authored by Li‐Chung Chiu

Since Specialization

Citations

This map shows the geographic impact of Li‐Chung Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Chung Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Chung Chiu more than expected).

Fields of papers citing papers by Li‐Chung Chiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Chung Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Chung Chiu. The network helps show where Li‐Chung Chiu may publish in the future.

Co-authorship network of co-authors of Li‐Chung Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Chung Chiu. A scholar is included among the top collaborators of Li‐Chung Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Chung Chiu. Li‐Chung Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsu, Chih‐Hung, Li‐Chung Chiu, Chih‐Hsi S. Kuo, et al.. (2025). Clinical outcome analysis of different first‑ and second‑generation EGFR‑tyrosine kinase inhibitors in untreated patients with EGFR‑mutated non‑small cell lung cancer with baseline brain metastasis. Oncology Letters. 29(4). 1–12. 1 indexed citations

Chang, Ko‐Wei, Shaw‐Woei Leu, Han‐Chung Hu, et al.. (2025). The Mechanical Power in Patients with Acute Respiratory Distress Syndrome Undergoing Prone Positioning Can Predict Mortality. Diagnostics. 15(2). 158–158. 2 indexed citations

Chiu, Li‐Chung, Chi-Jen Lo, Hsiang-Yu Tang, et al.. (2025). Plasma phenylalanine is associated with hospital mortality in acute respiratory distress syndrome: a prospective metabolic profiling cohort study. European journal of medical research. 30(1). 833–833.

Chiu, Li‐Chung, et al.. (2024). Factors associated with prolonged progression‐free survival of patients treated with first‐line afatinib for advanced epidermal growth factor receptor‐mutated non‐small cell lung cancer. Thoracic Cancer. 15(7). 529–537. 2 indexed citations

Hsu, Ping‐Chih, Chin‐Chou Wang, Li‐Chung Chiu, et al.. (2024). A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer. Vaccines. 12(5). 474–474. 1 indexed citations

Chiu, Li‐Chung, Chung-Shu Lee, Ping‐Chih Hsu, et al.. (2024). Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study. Environmental Health. 23(1). 29–29. 2 indexed citations

Hsu, Ping‐Chih, Li‐Chung Chiu, Chung-Shu Lee, et al.. (2023). Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan. Targeted Oncology. 18(2). 195–207. 15 indexed citations

Hsu, Ping‐Chih, Yu‐Ching Lin, Li‐Chung Chiu, et al.. (2023). Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors. Frontiers in Oncology. 13. 1249106–1249106. 1 indexed citations

Chiu, Li‐Chung, Hsiang-Yu Tang, Chi-Jen Lo, et al.. (2022). Kynurenine Pathway of Tryptophan Metabolism Is Associated with Hospital Mortality in Patients with Acute Respiratory Distress Syndrome: A Prospective Cohort Study. Antioxidants. 11(10). 1884–1884. 9 indexed citations

10.

Lee, Chung-Shu, Li‐Chung Chiu, Chih-Hao Chang, et al.. (2022). The Clinical Experience of Mycobacterial Culture Yield of Pleural Tissue by Pleuroscopic Pleural Biopsy among Tuberculous Pleurisy Patients. Medicina. 58(9). 1280–1280. 3 indexed citations

11.

Lin, Yu‐Ching, Li‐Chung Chiu, Shih‐Hong Li, et al.. (2022). Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study. Therapeutic Advances in Medical Oncology. 14. 4287525310–4287525310. 7 indexed citations

12.

Chiu, Li‐Chung, Ping‐Chih Hsu, Tzung‐Hai Yen, et al.. (2021). Blood Cadmium Levels and Oxygen Desaturation during the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease. Medicina. 57(11). 1160–1160. 3 indexed citations

13.

Chuang, Li‐Pang, Huang-Pin Wu, Li‐Ang Lee, et al.. (2021). Elevated Monocytic Interleukin-8 Expression under Intermittent Hypoxia Condition and in Obstructive Sleep Apnea Patients. International Journal of Molecular Sciences. 22(21). 11396–11396. 5 indexed citations

14.

Chiu, Li‐Chung, Shu‐Min Lin, Yu‐Lun Lo, et al.. (2021). Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC). Vaccines. 9(7). 689–689. 14 indexed citations

15.

Chiu, Li‐Chung, Shih‐Wei Lin, Li‐Pang Chuang, et al.. (2021). Mechanical power during extracorporeal membrane oxygenation and hospital mortality in patients with acute respiratory distress syndrome. Critical Care. 25(1). 13–13. 33 indexed citations

16.

Chu, Chien‐Ming, Li‐Chung Chiu, Chung‐Chieh Yu, et al.. (2021). Increased Death of Peripheral Blood Mononuclear Cells after TLR4 Inhibition in Sepsis Is Not via TNF/TNF Receptor‐Mediated Apoptotic Pathway. Mediators of Inflammation. 2021(1). 2255017–2255017. 7 indexed citations

17.

Chiu, Li‐Chung, Shih‐Wei Lin, Pi‐Hua Liu, et al.. (2020). Reclassifying severity after 48 hours could better predict mortality in acute respiratory distress syndrome. Therapeutic Advances in Respiratory Disease. 14. 3272671917–3272671917. 7 indexed citations

18.

Lin, Hui‐Ling, et al.. (2020). Hypertonic saline enhances the efficacy of aerosolized gentamicin against Pseudomonas aeruginosa. Scientific Reports. 10(1). 4325–4325. 7 indexed citations

19.

Chiu, Li‐Chung, Feng‐Chun Tsai, Han‐Chung Hu, et al.. (2014). Survival Predictors in Acute Respiratory Distress Syndrome With Extracorporeal Membrane Oxygenation. The Annals of Thoracic Surgery. 99(1). 243–250. 37 indexed citations

20.

Chiu, Li‐Chung, Tse‐Hung Huang, Kuo‐Chin Kao, et al.. (2013). Continuous Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment May Not Hinder the Survival of Patients with Primary Lung Adenocarcinoma despite Indolent New Lesions. 28(2). 73–88. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact